Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03276975 · ClinicalTrials.gov registry record · Phase 2
A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT03276975 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 15 participants.
The verdict
NCT03276975, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The goal of this randomized controlled trial (RCT) is to compare the efficacy of CT fluoroscopy-guided targeted epidural patching for treatment of imaging-confirmed spinal CSF leaks to that of a simulated procedure without patching material in patients with spontaneous intracranial hypotension.
Interventions
- DRUG TISSEEL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2020-03-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03276975
The ClinicalTrials.gov registry entry for NCT03276975 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TISSEEL is the first listed.
NCT03276975 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03276975 about?
NCT03276975 is a clinical study titled "A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment". The goal of this randomized controlled trial (RCT) is to compare the efficacy of CT fluoroscopy-guided targeted epidural patching for treatment of imaging-confirmed spinal CSF leaks to that of a simulated procedure without patching material in patients with spontaneous intracranial hypotension.
What is the current status of trial NCT03276975?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2017-12-18. Estimated completion is 2020-03-19.
What interventions are being tested in trial NCT03276975?
The interventions under investigation include: TISSEEL (DRUG).
Who is sponsoring clinical trial NCT03276975?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.